Blastomycosis in solid organ transplant recipients—A retrospective series from southeastern Wisconsin
- 19 June 2021
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 23 (4) , e13671
Abstract
Blastomycosis is a fungal infection caused primarily by Blastomyces dermatitis. The fungus is endemic to the Ohio, Mississippi, and St. Lawrence River areas of the United States. Organ transplant recipients are at risk of blastomycosis due to pharmacologic immunosuppression. Over a 20‐year period, 30 cases of blastomycosis post‐solid organ transplantation were identified at our center. The cumulative incidence of blastomycosis among SOT recipients was 0.99%. There was a male predominance (70% male) and a median age of 59 at the time of diagnosis. Regarding transplant type, 23 patients received kidney transplants, 4 received liver transplants, 2 received pancreas transplants and 1 received a heart transplant. Median time to blastomycosis identification post‐transplant was 67.8 months (range: 1‐188 months). Amphotericin B was used as initiation therapy in most cases, followed by itraconazole, voriconazole, or in select cases fluconazole or posaconazole maintenance therapy. Regarding comorbid conditions, 87% of patients had diabetes, 50% had congestive heart failure, and 20% had chronic pulmonary disease. Nine patients (30%) developed blastomycosis‐related acute respiratory distress syndrome, 33% of these died with a median time to death of 22 days (range 20 days to 2 months); these were the only deaths attributable to blastomycosis.Keywords
This publication has 24 references indexed in Scilit:
- Pulmonary BlastomycosisSeminars in Respiratory and Critical Care Medicine, 2011
- Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2008
- Blastomycosis in solid organ transplant recipientsTransplant Infectious Disease, 2007
- Immunosuppressive Drugs for Kidney TransplantationNew England Journal of Medicine, 2004
- Pharmacologic immunosuppressionFrontiers in Bioscience-Landmark, 2004
- Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor‐ and tumour necrosis factor‐receptor superfamily costimulatory moleculesImmunology, 2003
- BlastomycosisInfectious Disease Clinics of North America, 2003
- Azathioprine, Mycophenolate Mofetil, and Methotrexate Specifically Modulate Cytokine Production by T CellsAnnals of the New York Academy of Sciences, 1998
- Medical mycologyRevista do Instituto de Medicina Tropical de São Paulo, 1992
- Isolation ofBlastomyces dermatitidisin Soil Associated with a Large Outbreak of Blastomycosis in WisconsinNew England Journal of Medicine, 1986